Literature DB >> 326385

Combined chemo- and hormonal therapy in advanced breast cancer.

K W Brunner, R W Sonntag, P Alberto, H J Senn, G Martz, P Obrecht, P Maurice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 326385     DOI： 10.1002/1097-0142(197706)39:6<2923::aid-cncr2820390679>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

Review 1.  Current status and indications for adjuvant therapy in breast cancer.

Authors:  H J Senn
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 2.  Update on cancer chemotherapy: general considerations and breast cancer. Part II.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-09       Impact factor: 1.798

Review 3.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

4.  Chemoendocrine therapy in advanced breast cancer.

Authors:  D T Kiang; B J Kennedy
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: a sequential trial.

Authors:  T Wada; H Koyama; T Terasawa
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.

Authors:  F Cavalli; M Beer; G Martz; W F Jungi; P Alberto; J P Obrecht; B Mermillod; K W Brunner
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-01

Review 7.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.

Authors:  A Aitokallio-Tallberg; J Kärkkäinen; P Pantzar; T Wahlström; O Ylikorkala
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

9.  The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis.

Authors:  Yaling Wang; Lin He; Yuhua Song; Qian Wu; Haiji Wang; Biyuan Zhang; Xuezhen Ma
Journal:  BMC Womens Health       Date:  2020-01-31       Impact factor: 2.809

10.  Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.

Authors:  R Clarke; H W Van den Berg; D G Kennedy; R F Murphy
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.